- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01628302
Effect of Salt Restriction on Renin Activation
Investigation of Salt Restriction Effect on Renin Activation
The present prospective, randomized, crossover study is designed to investigate the effect of salt consumption on blood pressure in hypertensive subjects.
Secondary objectives of the study are to evaluate the effect of salt consumption on blood pressure among the subjects who are hypertensive and obese and normal according to body mass index and to evaluate the effect of salt consumption on renin activity in hypertensive subjects.
Study Overview
Detailed Description
The present study is carried out with the subjects who are chosen among the nursing home residents in İzmir. The subjects were randomized to 2 groups and while one of these groups had low salt diet (50mmol), the other group had normal salt diet (250mmol) for 3 weeks. Subjects had normal salt diet in their daily routine life for the following 2 weeks. According to crossover nature of the study, the group that had normal salt diet at the first 3 weeks of study had low salt diet at the last 3 weeks of the study. The other group that had low salt diet had the normal salt diet at the last 3 week of the study.
At the beginning of the study, information such as demographic, family story, medical story, diet habits, concomitant medication and physical measurements (height, weight and waist circumference) were received from the subjects.
24 hour blood pressure of the subjects is measured for four times, before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet. The subjects were asked for collecting 24-h urine in the same days of blood pressure measurement. Sodium, potassium, urea, creatinin and microalbumin measurements were measured in the collected urine. Blood samples were collected for three times, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet. Plasma renin activity and aldosterone levels were measured in the blood samples collected. Aldosterone level was measured in the 24-hour urine in mentioned days.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects who are 50 years and older
- Subjects whose systolic blood pressure is ≥ 140 mmHg
- Subjects whose diastolic blood pressure is ≥ 90 mmHg
- Subjects who is normal weighted defined as body mass index < 25 or who is obese defined as body mass index > 30
- Subjects who have intellectual capacity to adapt diets and 24 hour urine collection
- Informed about the study and consented to include the study
Exclusion Criteria:
- Known heart failure
- Known renal failure
- Known chronic liver disease
- Antihypertensive drug use
- nonsteroidal anti inflammatory (NSAI) drug use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Normal salt diet
The group had normal salt diet (250mmol)for three weeks.
Subjects had normal salt diet in their daily routine life for the following 2 weeks.According to crossover nature of the study, the group had low salt diet (50mmol) at the last 3 weeks of the study.
|
|
Experimental: Low salt diet
The group had low salt diet (50mmol)for three weeks.
Subjects had normal salt diet in their daily routine life for the following 2 weeks.According to crossover nature of the study, the group had normal salt diet at the last 3 weeks of the study.
|
Low salt diet (50mmol)for three weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in 24-hour ambulatory blood pressure at 3 weeks
Time Frame: 3 weeks
|
24-hour ambulatory blood pressure was measured before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in sodium levels in urine samples.
Time Frame: 3 weeks
|
Sodium was measured in 24-hour collected urine samples before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
3 weeks
|
Change in plasma renin activity
Time Frame: For 3 times in 8 weeks
|
Plasma renin activity level was measured in the blood samples collected, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
For 3 times in 8 weeks
|
Change in aldosterone level in blood samples
Time Frame: For 3 times in 8 weeks
|
Aldosterone levels was measured in the blood samples collected , at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
For 3 times in 8 weeks
|
Change in potassium levels in urine samples.
Time Frame: 3 weeks
|
Potassium was measured in 24-hour collected urine samples before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
3 weeks
|
Change in urea level in urine samples
Time Frame: 3 weeks
|
Urea was measured in 24-hour collected urine samples before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet
|
3 weeks
|
Change in creatinin level in urine samples
Time Frame: 3 weeks
|
Creatinin was measured in 24-hour collected urine samples before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
3 weeks
|
Change in microalbumin level in urine samples
Time Frame: 3 weeks
|
Microalbumin was measured in 24-hour collected urine samples before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet
|
3 weeks
|
Change in aldosterone level in urine samples
Time Frame: For 3 times in 8 weeks
|
Aldosterone levels was measured in in the 24-hour urine samples collected , at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
For 3 times in 8 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mustafa Arici, Prof., Hacettepe University Faculty of Medicine Department of Nephrology
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HT-Salt
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
Clinical Trials on Lowering salt in diet
-
University of Southern DenmarkOdense University Hospital; Beckett Foundation; Danish Diabetes AcademyCompleted
-
Peter GædeActive, not recruiting
-
University College CorkCompletedElevated Blood PressureIreland
-
Vanderbilt UniversityCompleted
-
Brigham and Women's HospitalTerminatedAutoimmunity | Sodium Chloride | Salt Intake | Th17 Helper Immune CellsUnited States
-
Vanderbilt University Medical CenterCompletedObesity | Cardiovascular Risk Factor | Salt; ExcessUnited States
-
University of MichiganRenal Research InstituteCompletedKidney DiseaseUnited States
-
Aga Khan UniversityWellcome TrustUnknown
-
Hospital Clínico Universitario de ValladolidUnknown
-
Yale UniversityCompletedAutoimmune Hepatitis